On February 26, 2021 Molecular Templates, Inc. (Nasdaq: MTEM, "Molecular Templates" or "MTEM"), a clinical-stage biopharmaceutical company focused on the discovery and development of the company’s proprietary engineered toxin bodies (ETBs), which are differentiated, targeted, biologic therapeutics for cancer and other serious diseases, reported that it will present and participate in 1-on-1 investor meetings at the Cowen 41st Annual Health Care Conference, the Barclays Global Healthcare Conference and the Oppenheimer 31st Annual Healthcare Conference (Press release, Molecular Templates, FEB 26, 2021, View Source [SID1234575759]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen 41st Annual Health Care Conference
Conference Dates: March 1-4
Presentation Date and Time: Thursday, March 4th at 11:10 AM ET

Barclays Global Healthcare Conference
Conference Dates: March 9-11
Presentation Date and Time: Wednesday, March 10th at 3:00 PM ET

Oppenheimer 31st Annual Healthcare Conference
Conference Dates: March 16-17
Presentation Date and Time: Wednesday, March 17th at 11:20 AM ET

Live webcasts of these presentations will be available in the "News and Events" section of the MTEM website at www.mtem.com. Additionally, replays of the webcasts will be available on the corporate website following the conferences.